Integrated acoustic dispensing and droplet microfluidics accelerate gene editing workflows

Explore an innovative high-throughput CRISPR screening workflow in drug discovery with Hugo Sinha, co-founder and COO of DropGenie. Its microfluidic platform is designed to reduce cellular input while maintaining efficiency and viability for genome-wide screening. Integrated automation enables thousands of edits per day, enhancing the efficiency and cost-effectiveness of drug discovery. In this video, Sinha demonstrates low-volume, high-throughput discovery using the Echo 655T and Biomek i7 hybrid liquid handlers form Beckman Coulter Life Sciences paired with the DropGenie platform.

This video was filmed at SLAS2024.